Video Experimental Relacionado
Updated: Sep 10, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
620
La obesidad: un modulador en el tratamiento del acné
Jean-Paul Claudel1, Fabienne Ballanger2, Nicole Auffret3
1Private practice, Tours, France.
Acta dermato-venereologica
|August 22, 2025
Resumen
La obesidad es un factor de riesgo significativo para la gravedad del acné en los adolescentes. Un enfoque integral que aborde los factores dermatológicos, nutricionales y de estilo de vida es crucial para manejar ambas afecciones de manera efectiva en pacientes obesos.
Área de la Ciencia:
- Dermatología
- Salud pública
- Trastornos del metabolismo
Sus antecedentes:
- El acné vulgaris es una afección inflamatoria común de la piel influenciada por varios factores.
- La obesidad es un problema de salud mundial, cada vez más relacionado con la gravedad del acné, especialmente en los adolescentes.
- Comprender la interacción entre la obesidad y el acné es vital para el tratamiento eficaz del paciente.
Objetivo del estudio:
- Analizar la literatura actual sobre la relación entre la obesidad y el acné vulgar.
- Explorar los aspectos epidemiológicos, patogenéticos y de gestión del acné en personas obesas.
- Proporcionar a los dermatólogos un marco para el manejo del acné en el contexto de la obesidad.
Principales métodos:
- Una revisión sistemática de la literatura de 52 artículos sobre el acné y la obesidad publicados desde el año 2000 de la base de datos de PubMed.
- Discusión y síntesis de los hallazgos por un panel de 5 dermatólogos franceses.
- Desarrollo de un árbol de decisión para el manejo del acné en pacientes obesos.
Principales resultados:
- Un alto índice de masa corporal es un factor de riesgo confirmado para la gravedad del acné.
- La obesidad y el acné comparten características metabólicas comunes, lo que sugiere la necesidad de un tratamiento integrado.
- Se recomienda un enfoque holístico que incluya apoyo dermatológico, endocrino, psicológico, nutricional y de estilo de vida.
Conclusiones:
- El tratamiento del acné en pacientes obesos requiere una estrategia paralela y global, no una tarea dermatológica aislada.
- La atención integrada puede conducir a mejoras tanto en el acné como en la obesidad.
- Un árbol de decisión propuesto tiene como objetivo guiar a los dermatólogos en la optimización del manejo del acné en pacientes obesos.
Videos de Conceptos Relacionados
Obesity
612
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
612
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Hypodermis
5.3K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
5.3K
Cholesterol: Significance and Regulation
678
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
678
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581

